TY - JOUR
T1 - Protective effects of hochu-ekki-to, a Chinese traditional herbal medicine against murine cytomegalovirus infection
AU - Hossain, M. Sohrab
AU - Takimoto, Hiroaki
AU - Hamano, Shinjiro
AU - Yoshida, Hiroki
AU - Ninomiya, Toshiharu
AU - Minamishima, Yoichi
AU - Kimura, Genki
AU - Nomoto, Kikuo
N1 - Funding Information:
We thank Dr. B. Quinn for proofreading and reviewing the manuscript. This work was supported by research grants from the Japanese Ministry of Education, Science and Culture.
PY - 1999/4
Y1 - 1999/4
N2 - The innate immunity against murine cytomegalovirus (MCMV) at the early phase of infection is mediated by NK cells and macrophages. We studied the effects of hochu-ekki-to (HET), a traditional Chinese herbal medicine, on the regulation of innate immunity mediated by NK cells and macrophages. We found the oral administration of HET to increase both the number of leukocytes in the spleen and liver and the splenic NK cell cytotoxicity associated with the increased induction of serum IFN-α/β after an MCMV infection but it had no effect on liver NK cells. However, no differences were found in the serum IL-12, IFN-γ, TNF-α and nitric oxide (NO) production in the culture of macrophages between the HET- and PBS-treated mice on day 2 after MCMV infection. In addition, HET-treated splenic and peritoneal macrophages were found to show a higher intrinsic resistance against in vitro MCMV infection than that of PBS-treated mice. Therefore, the HET-induced effects on NK cells and macrophages selectively reduced the viral load in the spleen but not in the liver at an early phase of MCMV infection. HET may thus be useful in the treatment of human cytomegalovirus infection which commonly occurs in HIV-infected AIDS patients. Copyright (C) 1999 Elsevier Science B.V.
AB - The innate immunity against murine cytomegalovirus (MCMV) at the early phase of infection is mediated by NK cells and macrophages. We studied the effects of hochu-ekki-to (HET), a traditional Chinese herbal medicine, on the regulation of innate immunity mediated by NK cells and macrophages. We found the oral administration of HET to increase both the number of leukocytes in the spleen and liver and the splenic NK cell cytotoxicity associated with the increased induction of serum IFN-α/β after an MCMV infection but it had no effect on liver NK cells. However, no differences were found in the serum IL-12, IFN-γ, TNF-α and nitric oxide (NO) production in the culture of macrophages between the HET- and PBS-treated mice on day 2 after MCMV infection. In addition, HET-treated splenic and peritoneal macrophages were found to show a higher intrinsic resistance against in vitro MCMV infection than that of PBS-treated mice. Therefore, the HET-induced effects on NK cells and macrophages selectively reduced the viral load in the spleen but not in the liver at an early phase of MCMV infection. HET may thus be useful in the treatment of human cytomegalovirus infection which commonly occurs in HIV-infected AIDS patients. Copyright (C) 1999 Elsevier Science B.V.
UR - http://www.scopus.com/inward/record.url?scp=0032980032&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032980032&partnerID=8YFLogxK
U2 - 10.1016/S0162-3109(98)00066-6
DO - 10.1016/S0162-3109(98)00066-6
M3 - Article
C2 - 10428645
AN - SCOPUS:0032980032
SN - 0162-3109
VL - 41
SP - 169
EP - 181
JO - Immunopharmacology
JF - Immunopharmacology
IS - 3
ER -